Get startedLog in
    Picture of HUTCHMED (China) logo

    13 — HUTCHMED (China) News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Hutchmed (China) Updates FY25 Guidance For Oncology/Immunology Consol Rev To $270M - $350M

    Picture of HUTCHMED (China) logoHUTCHMED (China)
    07/08/2025 16:13
    Aug 7 (Reuters) - HUTCHMED (China) Ltd 0013.HK:

UPDATES FY25 GUIDANCE FOR ONCOLOGY/IMMUNOLOGY CONSOL REVENUE TO $270 MILLION - $350 MILLION

Further company coverage: 0013.HK

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on HUTCHMED (China)

    See all news